TOPLINE: Chronic cutaneous immune-related adverse events (cirAEs) that develop after immune checkpoint inhibitor (ICI) therapy may require long-term follow-up. METHODOLOGY: A cohort study of 318 patients treated with ICIs from 2015 to 2022 identified 100 patients with cirAEs, of which 24 were chronic (persisting more than 3 months after treatment cessation). Analysis included 52 total […]
The post Chronic Skin Effects Persist After Cancer Immunotherapy first appeared on News Health.
Author : News Health
Publish date : 2025-03-12 15:00:00
Copyright for syndicated content belongs to the linked Source.